Xin Zhang

Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang.

Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang.

Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang.

Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China.

Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang.